ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
18.001,60
0,54%
S&P 500
5.127,79
1,26%
Dow Jones
38.675,68
1,18%
Euro vs US Dollar
1,07665
0,08%
Bitcoin
63.917,49
-0,13%
Registration Strip Icon for discussion Registrieren Sie sich, um in unseren aktiven Foren mit gleichgesinnten Anlegern zu diskutieren.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. Kanada
  5. TSX
  6. Trilogy International Partners Inc (TRL)

  7. Trilogy International Partners Inc (TRL) News

TRL

Trilogy International Pa... (TRL)

Trilogy International Partners Inc
Von:
Sortieren nach:
 Showing the most relevant articles for your search:TSX:TRL
DatumZeitQuelleÜberschriftSymbolFirma
07/02/202218h15PR Newswire (Canada)Suspension de la négociation par l'OCRCVM - TRL.WTTSX:TRLTrilogy International Partners Inc
07/02/202218h12PR Newswire (Canada)IIROC Trading Halt - TRL.WTTSX:TRLTrilogy International Partners Inc
07/10/202114h18PR Newswire (Canada)L'OCRCVM permet la reprise de la négociation - TRLTSX:TRLTrilogy International Partners Inc
07/10/202114h16PR Newswire (Canada)IIROC Trade Resumption - TRLTSX:TRLTrilogy International Partners Inc
06/10/202121h10PR Newswire (Canada)Suspension de la négociation par l'OCRCVM - TRLTSX:TRLTrilogy International Partners Inc
06/10/202121h09PR Newswire (Canada)IIROC Trading Halt - TRLTSX:TRLTrilogy International Partners Inc
15/02/201923h12PR Newswire (US)Phoenix Tower International expands footprint in South America with acquisition of 600 wireless communication tower sites fro...TSX:TRLTrilogy International Partners Inc
14/12/201819h37PR Newswire (Canada)L'OCRCVM permet la reprise de la négociation - TRLTSX:TRLTrilogy International Partners Inc
14/12/201819h36PR Newswire (Canada)IIROC Trade Resumption - TRLTSX:TRLTrilogy International Partners Inc
14/12/201814h39PR Newswire (Canada)Suspension de la négociation par l'OCRCVM - TRLTSX:TRLTrilogy International Partners Inc
14/12/201814h38PR Newswire (Canada)IIROC Trading Halt - TRLTSX:TRLTrilogy International Partners Inc
08/09/201723h45PR Newswire (Canada)S&P Dow Jones Indices Announces Changes to the S&P/TSX Canadian IndicesTSX:TRLTrilogy International Partners Inc
08/09/201723h42PR Newswire (Canada)S&P Dow Jones Indices annonce des modifications aux indices canadiens S&P/TSXTSX:TRLTrilogy International Partners Inc
16/03/201512h30PR Newswire (Canada)Endo Pharmaceuticals Announces the Launch of NATESTO™ (testosterone nasal gel), the First and Only Nasal Gel for Testostero...TSX:TRLTrilogy International Partners Inc
16/03/201512h30PR Newswire (US)Endo Pharmaceuticals Announces the Launch of NATESTO™ (testosterone nasal gel), the First and Only Nasal Gel for Testostero...TSX:TRLTrilogy International Partners Inc
16/03/201512h30PR Newswire (US)Endo Pharmaceuticals Announces the Launch of NATESTO™ (testosterone nasal gel), the First and Only Nasal Gel for Testostero...TSX:TRLTrilogy International Partners Inc
09/12/201413h00PR Newswire (Canada)Endo Completes Acquisition of Rights to Natesto™ Testosterone Nasal GelTSX:TRLTrilogy International Partners Inc
09/12/201413h00PR Newswire (US)Endo Completes Acquisition of Rights to Natesto™ Testosterone Nasal GelTSX:TRLTrilogy International Partners Inc
01/12/201414h34InvestorsHub NewsWireEDISON EQUITY RESEARCH - TRIMEL PHARMACEUTICALSTSX:TRLTrilogy International Partners Inc
20/10/201415h02InvestorsHub NewsWireEDISON EQUITY RESEARCH - TRIMEL PHARMACEUTICALSTSX:TRLTrilogy International Partners Inc
06/08/201406h27InvestorsHub NewsWireTrimel Pharmaceuticals - Seeking positive EBITDA with EstraceTSX:TRLTrilogy International Partners Inc
30/07/201415h15Marketwired CanadaTrimel Completes Private Placement of Common SharesTSX:TRLTrilogy International Partners Inc
28/07/201416h12InvestorsHub NewsWireTrimel Pharmaceuticals - A closer look at Tefina Phase II FOD resultsTSX:TRLTrilogy International Partners Inc
26/07/201400h31PR Newswire (Canada)Update to Early Warning Report for Trimel Pharmaceuticals CorporationTSX:TRLTrilogy International Partners Inc
17/07/201419h53PR Newswire (Canada)L’OCRCVM permet la reprise de la négociation - TRLTSX:TRLTrilogy International Partners Inc
17/07/201419h53PR Newswire (Canada)IIROC Trade Resumption - TRLTSX:TRLTrilogy International Partners Inc
17/07/201419h41PR Newswire (Canada)Suspension de la négociation par l'OCRCVM - TRLTSX:TRLTrilogy International Partners Inc
17/07/201419h41PR Newswire (Canada)IIROC Trading Halt - TRLTSX:TRLTrilogy International Partners Inc
17/07/201419h40Marketwired CanadaTrimel Pharmaceuticals Acquires Canadian Rights to Estrace®TSX:TRLTrilogy International Partners Inc
18/06/201421h00MarketwiredTrimel to Present at the JMP Securities Healthcare ConferenceTSX:TRLTrilogy International Partners Inc
 Showing the most relevant articles for your search:TSX:TRL

Kürzlich von Ihnen besucht

DBI
DAX
DAX
NYSE
MRK
Merck
PM
XAUUSD
Gold vs US Dollar
NYSE
XOM
Exxon Mobil
AMEX
XLE
Energy Select Sector SPDR
DBI
TDXP
Tec DAX
AMEX
XLV
Health Care Select Sector
TG
D7G
Nel ASA
USOTC
ADDYY
Adidas (QX)
COIN
SOLUSD
Solana
FX
EURGBP
Euro vs Sterling
CCOM
US100
US Tech 100
AMEX
SPY
SPDR S&P 500
DBI
SDXP
SDAX
NASDAQ
QQQ
Invesco QQQ Trust Series 1
TG
RHM
Rheinmetall
Delayed Upgrade Clock
ADVFN Logo

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2024 ADVFN PLC - Alle Rechte vorbehalten